Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape

• Ignacio Algarra, Angel Miguel Garcia-Lora, Teresa Cabrera, Francisco Javier Montes Ruiz-Cabello, Federico Garrido
• Cancer Immunology, Immunotherapy
• 2004

Tumor immune escape variants can be identified in human and experimental tumors. A variety of different strategies are used by tumor cells to avoid recognition by different immune effector… (More)

"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.

• Federico Garrido, Teresa Cabrera, Natalia Aptsiauri
• International journal of cancer
• 2010

The ability of cancer cells to escape from the natural or immunotherapy-induced antitumor immune response is often associated with alterations in the tumor cell surface expression of Major… (More)

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.

• Federico Garrido, Francisco Javier Montes Ruiz-Cabello, +4 authors Peter L. Stern
• Immunology today
• 1997

HLA class I downregulation is a frequent event associated with tumour invasion and development. Altered HLA class I tumour phenotypes can have profound effects on T-cell and natural killer (NK)-cell… (More)

HLA class I antigen abnormalities and immune escape by malignant cells.

• Barbara Seliger, Teresa Cabrera, Federico Garrido, Soldano Ferrone
• Seminars in cancer biology
• 2002

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.

• A. R. M. Serrano, Silvia Tanzarella, +4 authors Federico Garrido
• International journal of cancer
• 2001

Cell surface expression of HLA class I/peptide complexes on tumor cells is a key step in the generation of T-cell-based immune responses. Several genetic defects underlying the lack of HLA class I… (More)

Analysis of HLA-E expression in human tumors

• Rosario Marín, Francisco Javier Montes Ruiz-Cabello, +4 authors Federico Garrido
• Immunogenetics
• 2003

Downregulation of MHC class Ia molecule expression is a widespread mechanism used by tumor cells to escape antitumor T-cell-mediated immune responses. However, it is not known why NK cells cannot… (More)

Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

• Isabel Maleno, Miguel Ángel López-Nevot, Teresa Cabrera, José Salinero, Federico Garrido
• Cancer Immunology, Immunotherapy
• 2002

Major histocompatibility complex (MHC) class I loss or downregulation in cancer cells is a major immune escape route used by a large variety of human tumors to evade anti-tumor immune responses… (More)

Natural history of HLA expression during tumour development.

• Federico Garrido, Teresa Cabrera, Angel Concha Concha, Simon Glew, Francisco Javier Montes Ruiz-Cabello, Peter L. Stern
• Immunology today
• 1993

HLA expression is frequently altered in tumours compared to the tissue from which they originate. Given the central role of MHC products in the restriction of T-cell recognition, regulation of tumour… (More)

MHC antigens and tumor escape from immune surveillance.

• Federico Garrido, Ignacio Algarra
• Advances in cancer research
• 2001

A new extract of the plant calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation

• Eva E Jimenez-Medina, Angel Miguel Garcia-Lora, Laura Paco, Ignacio Algarra, Antonia A Collado, Federico Garrido
• BMC Cancer
• 2006

Phytopharmacological studies of different Calendula extracts have shown anti-inflamatory, anti-viral and anti-genotoxic properties of therapeutic interest. In this study, we evaluated the in vitro… (More)

• ‹
• 1
• 2
• 3
• 4
• 5
• ›